METHIMAZOLE

METHIMAZOLE was reported 7994 times

METHIMAZOLE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTITHYROID ARTHRITIS SYNDROME 25 0.9259
1 THYROTOXIC MYOPATHY 11 0.8462
2 NEONATAL THYROTOXICOSIS 9 0.3750
3 THYROID STIMULATING IMMUNOGLOBULIN INCREASED 20 0.2500
4 THYROTOXIC PERIODIC PARALYSIS 30 0.2055
5 DEAFNESS PERMANENT 40 0.2041
6 TOXIC GOITRE 10 0.1639
7 CHOANAL ATRESIA 16 0.1333
8 THYROTOXIC CRISIS 139 0.1221
9 STENOTROPHOMONAS MALTOPHILIA PNEUMONIA 8 0.1159
10 ENDOCRINE OPHTHALMOPATHY 91 0.1048
11 APLASIA CUTIS CONGENITA 14 0.0979
12 TOXIC NODULAR GOITRE 12 0.0909
13 PERICARDITIS FUNGAL 6 0.0909
14 AUTOPHONY 6 0.0800
15 ANTI-THYROID ANTIBODY INCREASED 10 0.0794
16 POST PROCEDURAL HYPOTHYROIDISM 10 0.0472
17 PLASMACYTOSIS 7 0.0366
18 INSULIN AUTOIMMUNE SYNDROME 12 0.0336
19 HYPERTHYROIDISM 416 0.0287
20 GINGIVITIS ULCERATIVE 6 0.0279
21 TRI-IODOTHYRONINE INCREASED 10 0.0251
22 THYROXINE FREE INCREASED 16 0.0250
23 EOSINOPHILIC PLEURAL EFFUSION 7 0.0235
24 CONGENITAL HYPOTHYROIDISM 6 0.0233
25 EXOMPHALOS 12 0.0223
26 LEFT-TO-RIGHT CARDIAC SHUNT 6 0.0203
27 BASEDOW'S DISEASE 9 0.0191
28 LOSS OF PROPRIOCEPTION 6 0.0186
29 DEAFNESS NEUROSENSORY 59 0.0179
30 ECTHYMA 7 0.0175
31 TYPE V HYPERLIPIDAEMIA 8 0.0165
32 LIP EROSION 12 0.0164
33 EXOPHTHALMOS 35 0.0163
34 AGRANULOCYTOSIS 261 0.0140
35 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 10 0.0136
36 ANTI-THYROID ANTIBODY POSITIVE 6 0.0131
37 GOITRE 52 0.0127
38 SKULL MALFORMATION 8 0.0124
39 THYROXINE FREE DECREASED 7 0.0124
40 THYROXINE INCREASED 8 0.0113
41 BLEEDING VARICOSE VEIN 6 0.0111
42 GASTROINTESTINAL MUCOSAL DISORDER 7 0.0107
43 EUSTACHIAN TUBE DYSFUNCTION 6 0.0104
44 CENTRAL SEROUS CHORIORETINOPATHY 7 0.0102
45 JAUNDICE CHOLESTATIC 36 0.0102
46 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 25 0.0101
47 CONSCIOUSNESS FLUCTUATING 10 0.0096
48 ISCHAEMIC HEPATITIS 13 0.0095
49 SKIN SENSITISATION 9 0.0087
50 PULSELESS ELECTRICAL ACTIVITY 35 0.0084
51 TWIN PREGNANCY 7 0.0083
52 DYSMORPHISM 18 0.0076
53 PHYSICAL DISABILITY 33 0.0075
54 BLOOD THYROID STIMULATING HORMONE DECREASED 33 0.0073
55 THYROIDECTOMY 12 0.0069
56 PAROTITIS 8 0.0069
57 AXIAL SPONDYLOARTHRITIS 6 0.0068
58 CHOLESTATIC LIVER INJURY 15 0.0067
59 THYROIDITIS 20 0.0067
60 THYROID MASS 25 0.0065
61 MEAN CELL VOLUME DECREASED 10 0.0065
62 NEONATAL RESPIRATORY DISTRESS 6 0.0064
63 VENTRICULAR DYSFUNCTION 15 0.0058
64 POLYARTHRITIS 30 0.0057
65 CONCOMITANT DISEASE AGGRAVATED 35 0.0057
66 HYPOTHYROIDISM 160 0.0050
67 RESPIRATORY SYNCYTIAL VIRUS INFECTION 43 0.0049
68 AUDITORY DISORDER 7 0.0049
69 ESSENTIAL HYPERTENSION 9 0.0049
70 THYROID FUNCTION TEST ABNORMAL 20 0.0048
71 CUTANEOUS VASCULITIS 17 0.0047
72 CARDIOGENIC SHOCK 66 0.0046
73 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 27 0.0044
74 THYROID DISORDER 68 0.0044
75 KOUNIS SYNDROME 10 0.0044
76 INFUSION SITE RASH 6 0.0044
77 CRYPTOCOCCOSIS 7 0.0043
78 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 6 0.0043
79 ESCHERICHIA BACTERAEMIA 10 0.0042
80 CHRONIC GASTRITIS 9 0.0040
81 SYSTEMIC CANDIDA 10 0.0040
82 BILIRUBIN CONJUGATED INCREASED 9 0.0038
83 HYPERSENSITIVITY VASCULITIS 10 0.0038
84 IMPAIRED QUALITY OF LIFE 54 0.0038
85 EAR DISCOMFORT 37 0.0036
86 HEPATITIS CHOLESTATIC 21 0.0035
87 PAPILLARY THYROID CANCER 6 0.0034
88 TONSILLITIS 18 0.0034
89 MIXED LIVER INJURY 10 0.0033
90 PHARYNGEAL ERYTHEMA 7 0.0033
91 PNEUMONIA KLEBSIELLA 6 0.0033
92 INFUSION SITE BRUISING 7 0.0032
93 CATHETER PLACEMENT 6 0.0032
94 AUTOIMMUNE THYROIDITIS 12 0.0032
95 HAEMODYNAMIC INSTABILITY 24 0.0031
96 DRUG-INDUCED LIVER INJURY 97 0.0031
97 NASAL SEPTUM DEVIATION 6 0.0031
98 CLONUS 8 0.0029
99 PULMONARY ALVEOLAR HAEMORRHAGE 16 0.0028
100 LABYRINTHITIS 7 0.0028
101 MONOCYTE COUNT INCREASED 10 0.0028
102 PERICARDIAL HAEMORRHAGE 6 0.0027
103 THERAPEUTIC REACTION TIME DECREASED 8 0.0027
104 PRODUCT USE COMPLAINT 43 0.0027
105 ORAL DISORDER 20 0.0027
106 INFUSION SITE SWELLING 17 0.0027
107 IRON DEFICIENCY 12 0.0027
108 COMPUTERISED TOMOGRAM ABNORMAL 6 0.0026
109 DISTRIBUTIVE SHOCK 6 0.0026
110 TINNITUS 121 0.0026
111 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 7 0.0026
112 HYPERTONIA 15 0.0026
113 DIASTOLIC DYSFUNCTION 8 0.0026
114 EAR CONGESTION 7 0.0026
115 INFUSION SITE INFECTION 6 0.0026
116 RED BLOOD CELL COUNT INCREASED 7 0.0025
117 INFUSION SITE PRURITUS 8 0.0025
118 ACUTE PULMONARY OEDEMA 14 0.0025
119 LYMPHOCYTE COUNT INCREASED 8 0.0024
120 EYELID MARGIN CRUSTING 7 0.0024
121 HYPERPARATHYROIDISM SECONDARY 6 0.0024
122 POTENTIATING DRUG INTERACTION 8 0.0024
123 STRABISMUS 7 0.0024
124 ECONOMIC PROBLEM 36 0.0024
125 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 12 0.0023
126 VENTRICULAR FIBRILLATION 26 0.0023
127 ONYCHOCLASIS 16 0.0023
128 KIDNEY TRANSPLANT REJECTION 11 0.0023
129 SINUS BRADYCARDIA 22 0.0023
130 NEONATAL RESPIRATORY DISTRESS SYNDROME 8 0.0023
131 PHARYNGOLARYNGEAL PAIN 12 0.0023
132 BLOOD CREATININE DECREASED 7 0.0022
133 HYPERACUSIS 8 0.0021
134 PURPURA 19 0.0021
135 LOW BIRTH WEIGHT BABY 17 0.0021
136 HYPERBILIRUBINAEMIA 22 0.0021
137 LEFT VENTRICULAR HYPERTROPHY 9 0.0021
138 DIPLOPIA 54 0.0021
139 OCULAR ICTERUS 9 0.0021
140 PREMATURE DELIVERY 33 0.0021
141 DYSPNOEA AT REST 6 0.0021
142 BLOOD THYROID STIMULATING HORMONE INCREASED 19 0.0021
143 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 16 0.0021
144 GASTROINTESTINAL NECROSIS 6 0.0021
145 INFUSION SITE REACTION 6 0.0020
146 TRIGEMINAL NEURALGIA 8 0.0020
147 ACUTE HEPATIC FAILURE 27 0.0020
148 PREMATURE BABY 59 0.0020
149 INFUSION SITE PAIN 25 0.0019
150 RED CELL DISTRIBUTION WIDTH INCREASED 8 0.0019
151 CARDIAC TAMPONADE 9 0.0019
152 POLYMYALGIA RHEUMATICA 6 0.0019
153 ORTHOPNOEA 6 0.0019
154 STEVENS-JOHNSON SYNDROME 41 0.0018
155 INFUSION SITE HAEMORRHAGE 6 0.0018
156 CARDIAC FAILURE ACUTE 12 0.0018
157 HIGH DENSITY LIPOPROTEIN DECREASED 6 0.0018
158 RHINITIS ALLERGIC 8 0.0018
159 ERYSIPELAS 9 0.0018
160 HYPERCALCAEMIA 22 0.0018
161 HEPATIC CYST 6 0.0018
162 ISCHAEMIA 8 0.0017
163 MULTIPLE ORGAN DYSFUNCTION SYNDROME 49 0.0017
164 NEPHROGENIC ANAEMIA 8 0.0017
165 APLASTIC ANAEMIA 9 0.0017
166 HANGOVER 6 0.0017
167 HEART DISEASE CONGENITAL 6 0.0017
168 MATERNAL DRUGS AFFECTING FOETUS 13 0.0017
169 BRAIN INJURY 17 0.0017
170 SYMPTOM RECURRENCE 10 0.0017
171 CHOLESTASIS 32 0.0017
172 INFUSION SITE ERYTHEMA 14 0.0017
173 TYPE 1 DIABETES MELLITUS 10 0.0017
174 LUPUS-LIKE SYNDROME 15 0.0017
175 TEMPERATURE INTOLERANCE 17 0.0016
176 IRON DEFICIENCY ANAEMIA 15 0.0016
177 HYPERVOLAEMIA 8 0.0016
178 LIVER INJURY 39 0.0016
179 UPPER-AIRWAY COUGH SYNDROME 13 0.0016
180 ENTEROCOLITIS 9 0.0016
181 VITAMIN D DEFICIENCY 15 0.0015
182 TREATMENT NONCOMPLIANCE 84 0.0015
183 BODY TEMPERATURE DECREASED 15 0.0015
184 VENTRICULAR TACHYCARDIA 25 0.0015
185 ODYNOPHAGIA 9 0.0015
186 HEPATIC ENCEPHALOPATHY 14 0.0015
187 BLEPHARITIS 6 0.0015
188 YELLOW SKIN 7 0.0015
189 FOOD POISONING 8 0.0015
190 LIVER FUNCTION TEST INCREASED 32 0.0015
191 SINUS TACHYCARDIA 21 0.0015
192 TASTE DISORDER 30 0.0015
193 ABNORMAL LOSS OF WEIGHT 10 0.0015
194 DISABILITY 29 0.0015
195 ECCHYMOSIS 10 0.0015
196 HAIR DISORDER 12 0.0015
197 CONJUNCTIVITIS 27 0.0015
198 JAUNDICE 39 0.0014
199 GUILLAIN-BARRE SYNDROME 7 0.0014
200 HYPERTHERMIA 11 0.0014
201 EAR PAIN 28 0.0014
202 LIVE BIRTH 12 0.0014
203 BUNDLE BRANCH BLOCK LEFT 6 0.0014
204 PERIORBITAL SWELLING 8 0.0014
205 PULMONARY MASS 21 0.0014
206 BLOOD ALKALINE PHOSPHATASE INCREASED 35 0.0014
207 ABSCESS LIMB 6 0.0014
208 CARDIAC ARREST 116 0.0014
209 TORSADE DE POINTES 11 0.0014
210 PROCTALGIA 9 0.0014
211 PSEUDOMONAS INFECTION 12 0.0014
212 HORDEOLUM 6 0.0014
213 ATRIOVENTRICULAR BLOCK FIRST DEGREE 6 0.0014
214 ATRIAL FLUTTER 11 0.0014
215 NEUTROPHIL COUNT INCREASED 14 0.0014
216 MYASTHENIA GRAVIS 11 0.0014
217 GINGIVAL SWELLING 6 0.0014
218 CARDIAC FAILURE 108 0.0013
219 CARDIOTOXICITY 12 0.0013
220 ILEUS PARALYTIC 6 0.0013
221 SEASONAL ALLERGY 19 0.0013
222 ATRIAL FIBRILLATION 130 0.0013
223 CATATONIA 7 0.0013
224 FOETAL EXPOSURE DURING PREGNANCY 107 0.0013
225 LIGAMENT SPRAIN 13 0.0013
226 THERAPY NON-RESPONDER 59 0.0013
227 IMMUNE THROMBOCYTOPENIA 6 0.0013
228 UPPER GASTROINTESTINAL HAEMORRHAGE 22 0.0013
229 HYPERTRANSAMINASAEMIA 9 0.0013
230 GENERALISED OEDEMA 16 0.0013
231 PANCYTOPENIA 72 0.0013
232 SEPTIC SHOCK 56 0.0013
233 NEPHROPATHY 12 0.0013
234 SWELLING OF EYELID 8 0.0013
235 INTESTINAL ISCHAEMIA 7 0.0013
236 CHOKING SENSATION 7 0.0013
237 PULSE ABSENT 6 0.0013
238 HYPERLIPIDAEMIA 15 0.0013
239 SUPRAVENTRICULAR TACHYCARDIA 12 0.0013
240 OSTEOPENIA 19 0.0013
241 OCULAR DISCOMFORT 14 0.0012
242 DISCOMFORT 76 0.0012
243 ATELECTASIS 12 0.0012
244 REBOUND EFFECT 14 0.0012
245 MITRAL VALVE INCOMPETENCE 14 0.0012
246 MAJOR DEPRESSION 9 0.0012
247 GRANULOCYTOPENIA 7 0.0012
248 GLYCOSYLATED HAEMOGLOBIN INCREASED 31 0.0012
249 CARDIOMEGALY 15 0.0012
250 EXERCISE TOLERANCE DECREASED 7 0.0012
251 PHARYNGITIS 15 0.0012
252 CAESAREAN SECTION 14 0.0012
253 PANCREATITIS ACUTE 27 0.0012
254 HYPERKALAEMIA 42 0.0012
255 SPLENOMEGALY 14 0.0012
256 HYPOKALAEMIA 55 0.0012
257 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 6 0.0012
258 HEPATIC STEATOSIS 22 0.0012
259 ENCEPHALOPATHY 29 0.0012
260 SHOCK 27 0.0012
261 RESPIRATION ABNORMAL 8 0.0012
262 ADRENAL INSUFFICIENCY 14 0.0012
263 END STAGE RENAL DISEASE 21 0.0012
264 FOETAL GROWTH RESTRICTION 7 0.0012
265 AUTOIMMUNE HEPATITIS 8 0.0011
266 ACUTE RESPIRATORY FAILURE 22 0.0011
267 LEUKOPENIA 57 0.0011
268 GLOMERULAR FILTRATION RATE DECREASED 14 0.0011
269 PULMONARY CONGESTION 15 0.0011
270 TRICUSPID VALVE INCOMPETENCE 9 0.0011
271 PULMONARY TOXICITY 8 0.0011
272 AUTOIMMUNE DISORDER 11 0.0011
273 HAIR TEXTURE ABNORMAL 15 0.0011
274 FACIAL PAIN 10 0.0011
275 COMPRESSION FRACTURE 6 0.0011
276 ANAL FISSURE 6 0.0011
277 VASCULITIS 13 0.0011
278 DECUBITUS ULCER 9 0.0011
279 GINGIVAL BLEEDING 15 0.0011
280 FOREIGN BODY SENSATION IN EYES 7 0.0011
281 PNEUMONIA BACTERIAL 10 0.0011
282 BLOOD PRESSURE DIASTOLIC DECREASED 8 0.0011
283 FOOT DEFORMITY 12 0.0011
284 HEPATOTOXICITY 24 0.0011
285 HEART RATE ABNORMAL 6 0.0011
286 BLOOD UREA INCREASED 18 0.0011
287 BLOOD BILIRUBIN INCREASED 29 0.0011
288 RESPIRATORY FAILURE 78 0.0011
289 ORAL CANDIDIASIS 14 0.0011
290 HEPATIC FAILURE 32 0.0011
291 BRADYCARDIA 56 0.0011
292 SPUTUM DISCOLOURED 10 0.0011
293 VITAMIN D DECREASED 9 0.0011
294 BLOOD POTASSIUM INCREASED 17 0.0010
295 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
296 BREAST MASS 7 0.0010
297 CARDIAC MURMUR 9 0.0010
298 PERICARDIAL EFFUSION 24 0.0010
299 PLEURAL EFFUSION 63 0.0010
300 MADAROSIS 12 0.0010
301 OCULAR HYPERAEMIA 49 0.0010
302 EXPOSURE DURING PREGNANCY 64 0.0010
303 BRAIN OEDEMA 13 0.0010
304 EYE PAIN 58 0.0010
305 GENERALISED TONIC-CLONIC SEIZURE 17 0.0010
306 CHRONIC KIDNEY DISEASE 78 0.0010
307 AKATHISIA 14 0.0010
308 SPINAL OSTEOARTHRITIS 9 0.0010
309 EYE SWELLING 38 0.0010
310 ELECTROCARDIOGRAM ABNORMAL 8 0.0010
311 PRODUCT ADMINISTRATION INTERRUPTED 8 0.0010
312 INTERNATIONAL NORMALISED RATIO INCREASED 29 0.0010
313 JOINT EFFUSION 7 0.0010
314 BLOOD IRON DECREASED 12 0.0010
315 PHOTOPHOBIA 19 0.0010
316 PRODUCT DISPENSING ERROR 22 0.0010
317 DISEASE RECURRENCE 48 0.0010
318 HAEMATOCRIT DECREASED 20 0.0010
319 PULMONARY HYPERTENSION 21 0.0010
320 SCIATICA 16 0.0010
321 HYPOTONIA 10 0.0010
322 ELECTROCARDIOGRAM QT PROLONGED 36 0.0010
323 HYPOACUSIS 43 0.0010
324 DISSEMINATED INTRAVASCULAR COAGULATION 14 0.0010
325 LYMPHOPENIA 14 0.0010
326 NOCTURIA 12 0.0010
327 MUSCLE SPASMS 181 0.0010
328 FEBRILE NEUTROPENIA 65 0.0010
329 POLYURIA 8 0.0010
330 BLOOD PRESSURE SYSTOLIC INCREASED 19 0.0010
331 INTERVERTEBRAL DISC DEGENERATION 9 0.0010
332 QUALITY OF LIFE DECREASED 13 0.0010
333 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 53 0.0010
334 HAIR COLOUR CHANGES 12 0.0010
335 FAECES SOFT 7 0.0010
336 PNEUMONIA ASPIRATION 24 0.0010
337 LACERATION 9 0.0010
338 MOUTH HAEMORRHAGE 7 0.0010
339 SENSATION OF FOREIGN BODY 8 0.0009
340 BLOOD URINE PRESENT 18 0.0009
341 CARDIOMYOPATHY 14 0.0009
342 MUSCLE ATROPHY 12 0.0009
343 CEREBRAL DISORDER 7 0.0009
344 RESPIRATORY TRACT CONGESTION 15 0.0009
345 BODY HEIGHT DECREASED 10 0.0009
346 IRRITABLE BOWEL SYNDROME 20 0.0009
347 HAEMOPTYSIS 26 0.0009
348 PALPITATIONS 109 0.0009
349 PSYCHOLOGICAL TRAUMA 8 0.0009
350 HEPATITIS ACUTE 6 0.0009
351 LIMB INJURY 25 0.0009
352 TROPONIN INCREASED 7 0.0009
353 AORTIC ANEURYSM 7 0.0009
354 RENAL TUBULAR NECROSIS 9 0.0009
355 LOCAL SWELLING 16 0.0009
356 BEDRIDDEN 12 0.0009
357 LUNG INFILTRATION 8 0.0009
358 CONGENITAL ANOMALY 7 0.0009
359 DYSPNOEA EXERTIONAL 34 0.0009
360 APHTHOUS ULCER 7 0.0009
361 HEPATITIS 23 0.0009
362 PULMONARY ARTERIAL HYPERTENSION 13 0.0009
363 SWOLLEN TONGUE 28 0.0009
364 GASTROINTESTINAL INFLAMMATION 7 0.0009
365 FLUID OVERLOAD 13 0.0009
366 NEUTROPENIA 121 0.0009
367 HEMIPARESIS 15 0.0009
368 EMOTIONAL DISTRESS 107 0.0009
369 CIRCULATORY COLLAPSE 15 0.0009
370 EXOSTOSIS 8 0.0009
371 MUSCLE DISORDER 7 0.0009
372 OROPHARYNGEAL PAIN 80 0.0009
373 WEIGHT FLUCTUATION 9 0.0009
374 DEFAECATION URGENCY 6 0.0009
375 TACHYCARDIA 76 0.0009
376 ABNORMAL FAECES 7 0.0009
377 DRUG EXPOSURE DURING PREGNANCY 29 0.0009
378 ESCHERICHIA INFECTION 7 0.0009
379 BLOOD SODIUM DECREASED 16 0.0008
380 CLOSTRIDIUM DIFFICILE COLITIS 9 0.0008
381 HAND FRACTURE 6 0.0008
382 ACUTE CORONARY SYNDROME 7 0.0008
383 DEVICE RELATED INFECTION 13 0.0008
384 FEAR OF INJECTION 6 0.0008
385 BONE MARROW FAILURE 17 0.0008
386 SARS-COV-2 TEST POSITIVE 11 0.0008
387 BRAIN FOG 13 0.0008
388 CANDIDA INFECTION 14 0.0008
389 SKIN LACERATION 9 0.0008
390 PRODUCT USE IN UNAPPROVED INDICATION 203 0.0008
391 EPISTAXIS 61 0.0008
392 UNRESPONSIVE TO STIMULI 21 0.0008
393 THERAPY CHANGE 8 0.0008
394 BLOOD PRESSURE DECREASED 54 0.0008
395 LOWER GASTROINTESTINAL HAEMORRHAGE 6 0.0008
396 BLOOD MAGNESIUM DECREASED 7 0.0008
397 MYOPATHY 7 0.0008
398 HOSPICE CARE 8 0.0008
399 MATERNAL EXPOSURE DURING PREGNANCY 72 0.0008
400 FEELING DRUNK 6 0.0008
401 PERIPHERAL COLDNESS 11 0.0008
402 TUBULOINTERSTITIAL NEPHRITIS 15 0.0008
403 OVARIAN CYST 8 0.0008
404 NAIL DISORDER 7 0.0008
405 BLOOD CALCIUM INCREASED 7 0.0008
406 PRODUCTIVE COUGH 38 0.0008
407 LACRIMATION INCREASED 24 0.0008
408 PRODUCT COMMUNICATION ISSUE 7 0.0008
409 ACUTE RESPIRATORY DISTRESS SYNDROME 14 0.0008
410 ACUTE KIDNEY INJURY 121 0.0008
411 SLEEP APNOEA SYNDROME 15 0.0008
412 INSURANCE ISSUE 12 0.0008
413 ALOPECIA 154 0.0008
414 WHITE BLOOD CELL COUNT INCREASED 30 0.0008
415 GOUT 14 0.0008
416 ROTATOR CUFF SYNDROME 10 0.0008
417 DRUG RESISTANCE 20 0.0008
418 OSTEOARTHRITIS 33 0.0008
419 GASTROINTESTINAL HAEMORRHAGE 65 0.0008
420 LOW DENSITY LIPOPROTEIN INCREASED 6 0.0008
421 HIATUS HERNIA 10 0.0008
422 VENTRICULAR EXTRASYSTOLES 8 0.0008
423 PARALYSIS 11 0.0008
424 HAEMORRHAGIC STROKE 6 0.0008
425 ANXIETY 218 0.0008
426 PRODUCT USE ISSUE 143 0.0008
427 EYE DISORDER 25 0.0008
428 CONTUSION 73 0.0008
429 HALLUCINATION, VISUAL 16 0.0008
430 HYPOKINESIA 11 0.0008
431 SINUS DISORDER 15 0.0008
432 BLOOD ALBUMIN DECREASED 6 0.0008
433 CHOLECYSTITIS 9 0.0008
434 GINGIVAL PAIN 6 0.0008
435 NECK PAIN 42 0.0008
436 DIARRHOEA HAEMORRHAGIC 7 0.0007
437 ASCITES 22 0.0007
438 THYROID CANCER 9 0.0007
439 FLANK PAIN 7 0.0007
440 AMENORRHOEA 13 0.0007
441 HYPERGLYCAEMIA 27 0.0007
442 HYPOCALCAEMIA 14 0.0007
443 PHARYNGITIS STREPTOCOCCAL 8 0.0007
444 HYPOXIA 26 0.0007
445 FAECES DISCOLOURED 16 0.0007
446 DYSPHONIA 43 0.0007
447 MYALGIA 125 0.0007
448 LYMPHADENOPATHY 26 0.0007
449 GASTROOESOPHAGEAL REFLUX DISEASE 59 0.0007
450 BLOOD CREATINE PHOSPHOKINASE INCREASED 21 0.0007
451 OSTEOPOROSIS 30 0.0007
452 WHITE BLOOD CELL COUNT DECREASED 79 0.0007
453 FLUID RETENTION 37 0.0007
454 HEART RATE INCREASED 72 0.0007
455 DEAFNESS 19 0.0007
456 BLOOD COUNT ABNORMAL 11 0.0007
457 RESPIRATORY DISTRESS 20 0.0007
458 AGEUSIA 18 0.0007
459 COAGULOPATHY 12 0.0007
460 TRANSAMINASES INCREASED 16 0.0007
461 BLOOD PRESSURE INCREASED 110 0.0007
462 POLLAKIURIA 30 0.0007
463 GAIT INABILITY 24 0.0007
464 OSTEOMYELITIS 13 0.0007
465 MALNUTRITION 8 0.0007
466 COELIAC DISEASE 7 0.0007
467 BONE DISORDER 13 0.0007
468 TYPE 2 DIABETES MELLITUS 24 0.0007
469 WEIGHT DECREASED 199 0.0007
470 NEUTROPHIL COUNT DECREASED 29 0.0007
471 ANKLE FRACTURE 11 0.0007
472 EYE INFECTION 8 0.0007
473 HEPATOCELLULAR INJURY 10 0.0007
474 BLOOD CREATININE INCREASED 46 0.0007
475 DERMATITIS CONTACT 8 0.0007
476 SCAB 8 0.0007
477 DRY EYE 35 0.0007
478 SCAR 12 0.0007
479 ALANINE AMINOTRANSFERASE INCREASED 43 0.0007
480 SUBDURAL HAEMATOMA 10 0.0007
481 ANURIA 6 0.0007
482 INJURY 49 0.0007
483 EMPHYSEMA 7 0.0007
484 PNEUMOTHORAX 11 0.0007
485 THROAT IRRITATION 31 0.0007
486 ANOSMIA 10 0.0007
487 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 36 0.0007
488 FLATULENCE 39 0.0007
489 MENTAL STATUS CHANGES 19 0.0007
490 CONDITION AGGRAVATED 208 0.0007
491 GASTRITIS 18 0.0007
492 IMMUNE SYSTEM DISORDER 9 0.0007
493 NIGHT SWEATS 22 0.0007
494 DYSURIA 25 0.0007
495 LIMB DISCOMFORT 21 0.0007
496 RENAL FAILURE 90 0.0007
497 ASPARTATE AMINOTRANSFERASE INCREASED 36 0.0007
498 DRUG ERUPTION 12 0.0007
499 POOR VENOUS ACCESS 7 0.0007
500 DRUG EFFECT LESS THAN EXPECTED 10 0.0007
501 BACTERAEMIA 8 0.0007
502 EYE DISCHARGE 7 0.0007
503 OEDEMA PERIPHERAL 82 0.0007
504 HERNIA 13 0.0007
505 CARDIAC FAILURE CONGESTIVE 54 0.0007
506 UPPER RESPIRATORY TRACT INFECTION 31 0.0007
507 PAIN IN JAW 19 0.0007
508 MUSCULAR WEAKNESS 76 0.0007
509 MYOSITIS 6 0.0007
510 POLYNEUROPATHY 8 0.0007
511 WRIST FRACTURE 8 0.0007
512 OROPHARYNGEAL DISCOMFORT 6 0.0007
513 SCRATCH 7 0.0007
514 HYPOAESTHESIA ORAL 10 0.0007
515 ARTHRITIS 52 0.0007
516 TOXIC EPIDERMAL NECROLYSIS 10 0.0007
517 PROSTATIC SPECIFIC ANTIGEN INCREASED 9 0.0007
518 INCREASED TENDENCY TO BRUISE 6 0.0007
519 NERVOUSNESS 34 0.0007
520 PRURITUS GENERALISED 14 0.0006
521 HEPATIC ENZYME INCREASED 44 0.0006
522 EJECTION FRACTION DECREASED 10 0.0006
523 DEFORMITY 6 0.0006
524 BLOOD TEST ABNORMAL 9 0.0006
525 RENAL INJURY 19 0.0006
526 ASPIRATION 7 0.0006
527 GASTROINTESTINAL PAIN 7 0.0006
528 MELAENA 14 0.0006
529 CYANOSIS 10 0.0006
530 ARRHYTHMIA 30 0.0006
531 FOOT FRACTURE 12 0.0006
532 ABDOMINAL PAIN LOWER 16 0.0006
533 ABDOMINAL DISTENSION 66 0.0006
534 RIB FRACTURE 13 0.0006
535 TOOTH DISORDER 14 0.0006
536 OBSTRUCTIVE AIRWAYS DISORDER 7 0.0006
537 APHASIA 19 0.0006
538 BURNING SENSATION 44 0.0006
539 HEART RATE DECREASED 22 0.0006
540 INTRAOCULAR PRESSURE INCREASED 8 0.0006
541 BLOOD PRESSURE FLUCTUATION 15 0.0006
542 SINUSITIS 64 0.0006
543 RHABDOMYOLYSIS 26 0.0006
544 CHROMATURIA 14 0.0006
545 STATUS EPILEPTICUS 7 0.0006
546 HEART RATE IRREGULAR 14 0.0006
547 HYPOGLYCAEMIA 30 0.0006
548 DIZZINESS 308 0.0006
549 DYSSTASIA 18 0.0006
550 GALLBLADDER DISORDER 11 0.0006
551 IMPAIRED DRIVING ABILITY 7 0.0006
552 HAEMORRHOIDS 12 0.0006
553 PLATELET COUNT INCREASED 8 0.0006
554 ANAEMIA 117 0.0006
555 PHARYNGEAL SWELLING 6 0.0006
556 HYPOTENSION 123 0.0006
557 NASAL CONGESTION 36 0.0006
558 HEPATOMEGALY 6 0.0006
559 PRODUCT SUBSTITUTION ISSUE 35 0.0006
560 URINARY INCONTINENCE 18 0.0006
561 ASTHENIA 228 0.0006
562 DRUG INTERACTION 96 0.0006
563 FEELING HOT 37 0.0006
564 PULMONARY OEDEMA 27 0.0006
565 THERAPY INTERRUPTED 43 0.0006
566 BALANCE DISORDER 52 0.0006
567 ALTERED STATE OF CONSCIOUSNESS 13 0.0006
568 BLOOD POTASSIUM DECREASED 18 0.0006
569 PERIPHERAL SWELLING 92 0.0006
570 METABOLIC ACIDOSIS 19 0.0006
571 SINUS CONGESTION 8 0.0006
572 INFLUENZA 66 0.0006
573 HERPES ZOSTER 34 0.0006
574 HIP FRACTURE 19 0.0006
575 EYELID PTOSIS 6 0.0006
576 MACULAR DEGENERATION 7 0.0006
577 HYPERHIDROSIS 75 0.0006
578 FATIGUE 453 0.0006
579 MUSCULOSKELETAL CHEST PAIN 9 0.0006
580 THROMBOCYTOPENIA 65 0.0006
581 DYSPHAGIA 55 0.0006
582 BURSITIS 7 0.0006
583 CHEST DISCOMFORT 59 0.0006
584 INCREASED APPETITE 11 0.0006
585 INSOMNIA 153 0.0006
586 SEPSIS 64 0.0006
587 APHONIA 8 0.0006
588 POST PROCEDURAL COMPLICATION 11 0.0006
589 ILLNESS 59 0.0006
590 SEROTONIN SYNDROME 11 0.0006
591 MASS 8 0.0006
592 SKIN REACTION 8 0.0006
593 BRONCHITIS 42 0.0006
594 ABASIA 14 0.0006
595 DYSKINESIA 23 0.0006
596 LYMPHOCYTE COUNT DECREASED 10 0.0006
597 ULCER 9 0.0006
598 EYE PRURITUS 19 0.0006
599 OFF LABEL USE 495 0.0006
600 ANGIOEDEMA 25 0.0006
601 RASH ERYTHEMATOUS 27 0.0006
602 BACK PAIN 131 0.0006
603 URINARY TRACT INFECTION 96 0.0006
604 TOOTH EXTRACTION 7 0.0006
605 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 27 0.0006
606 RENAL IMPAIRMENT 47 0.0006
607 WHEEZING 33 0.0006
608 LETHARGY 32 0.0006
609 EYE IRRITATION 32 0.0006
610 PARAESTHESIA ORAL 8 0.0006
611 BACK DISORDER 9 0.0006
612 PARAESTHESIA 87 0.0006
613 SWELLING FACE 36 0.0006
614 TOOTHACHE 10 0.0006
615 BLISTER 31 0.0006
616 BIPOLAR DISORDER 6 0.0006
617 BACK INJURY 6 0.0006
618 DIABETES MELLITUS 42 0.0006
619 FLUSHING 56 0.0006
620 PRODUCT PRESCRIBING ISSUE 12 0.0006
621 HYPONATRAEMIA 31 0.0005
622 CARDIO-RESPIRATORY ARREST 23 0.0005
623 OESOPHAGITIS 6 0.0005
624 COUGH 154 0.0005
625 HEPATIC CYTOLYSIS 7 0.0005
626 TREMOR 91 0.0005
627 DECREASED APPETITE 127 0.0005
628 PRURITUS 210 0.0005
629 STAPHYLOCOCCAL INFECTION 18 0.0005
630 MYDRIASIS 7 0.0005
631 PRODUCT ADMINISTRATION ERROR 11 0.0005
632 ABDOMINAL DISCOMFORT 91 0.0005
633 DENTAL CARIES 6 0.0005
634 PSYCHOMOTOR HYPERACTIVITY 9 0.0005
635 GAMMA-GLUTAMYLTRANSFERASE INCREASED 12 0.0005
636 CONSTIPATION 118 0.0005
637 DRY SKIN 72 0.0005
638 DEMENTIA 15 0.0005
639 MUSCULOSKELETAL STIFFNESS 47 0.0005
640 BLOOD GLUCOSE INCREASED 101 0.0005
641 WEIGHT INCREASED 120 0.0005
642 NEURALGIA 13 0.0005
643 DIARRHOEA 345 0.0005
644 ARTHRALGIA 222 0.0005
645 BLOOD CALCIUM DECREASED 6 0.0005
646 GAIT DISTURBANCE 102 0.0005
647 ANHEDONIA 14 0.0005
648 HEADACHE 334 0.0005
649 HEPATIC CIRRHOSIS 10 0.0005
650 TOOTH INFECTION 7 0.0005
651 PRODUCT DOSE OMISSION IN ERROR 15 0.0005
652 MOBILITY DECREASED 38 0.0005
653 MYOCARDIAL ISCHAEMIA 6 0.0005
654 GASTRIC ULCER 10 0.0005
655 THERAPY CESSATION 27 0.0005
656 FEELING JITTERY 10 0.0005
657 WITHDRAWAL SYNDROME 22 0.0005
658 ANGINA PECTORIS 15 0.0005
659 PYREXIA 180 0.0005
660 FALL 172 0.0005
661 ELECTROLYTE IMBALANCE 6 0.0005
662 DELUSION 8 0.0005
663 JOINT INJURY 11 0.0005
664 PNEUMONITIS 14 0.0005
665 EOSINOPHILIA 9 0.0005
666 IMPAIRED GASTRIC EMPTYING 7 0.0005
667 THERAPY PARTIAL RESPONDER 8 0.0005
668 SKIN FISSURES 10 0.0005
669 PAIN 314 0.0005
670 INFLUENZA LIKE ILLNESS 42 0.0005
671 SKIN DISORDER 17 0.0005
672 VISUAL IMPAIRMENT 63 0.0005
673 HEAD DISCOMFORT 9 0.0005
674 DYSPEPSIA 50 0.0005
675 CHEST PAIN 94 0.0005
676 ABDOMINAL PAIN 118 0.0005
677 HYPERTENSION 107 0.0005
678 ACTIVITIES OF DAILY LIVING IMPAIRED 10 0.0005
679 BLOOD LACTATE DEHYDROGENASE INCREASED 8 0.0005
680 HALLUCINATION 38 0.0005
681 TRANSIENT ISCHAEMIC ATTACK 17 0.0005
682 ORAL DISCOMFORT 7 0.0005
683 INTERVERTEBRAL DISC PROTRUSION 11 0.0005
684 SKIN ULCER 13 0.0005
685 HYPOMAGNESAEMIA 7 0.0005
686 COORDINATION ABNORMAL 7 0.0005
687 COVID-19 88 0.0005
688 ABSCESS 8 0.0005
689 ABDOMINAL PAIN UPPER 103 0.0005
690 MYELOSUPPRESSION 18 0.0005
691 DRUG INEFFECTIVE 658 0.0005
692 DYSPNOEA 282 0.0005
693 LOCALISED INFECTION 12 0.0005
694 LIVER DISORDER 22 0.0005
695 MUSCLE TIGHTNESS 8 0.0005
696 RASH 215 0.0005
697 FEEDING DISORDER 10 0.0005
698 DRY MOUTH 40 0.0005
699 MIGRAINE 47 0.0005
700 INFECTION 71 0.0005
701 CYTOPENIA 6 0.0005
702 DELIRIUM 17 0.0005
703 NAUSEA 387 0.0005
704 CHOLELITHIASIS 16 0.0005
705 CATARACT 29 0.0005
706 MULTIPLE FRACTURES 8 0.0005
707 INJECTION SITE EXTRAVASATION 6 0.0005
708 PHOTOSENSITIVITY REACTION 8 0.0005
709 BACTERIAL INFECTION 9 0.0005
710 HEPATIC FUNCTION ABNORMAL 18 0.0005
711 LIVER FUNCTION TEST ABNORMAL 14 0.0005
712 FREQUENT BOWEL MOVEMENTS 13 0.0005
713 VISION BLURRED 66 0.0005
714 APATHY 7 0.0005
715 INTENTIONAL PRODUCT USE ISSUE 42 0.0005
716 HAEMOGLOBIN DECREASED 49 0.0005
717 VERTIGO 29 0.0005
718 MOUTH ULCERATION 10 0.0005
719 SKIN HAEMORRHAGE 7 0.0005
720 URTICARIA 79 0.0005
721 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 8 0.0005
722 COLON CANCER 7 0.0005
723 DIVERTICULITIS 13 0.0005
724 PLATELET COUNT DECREASED 50 0.0005
725 GLAUCOMA 9 0.0005
726 MOVEMENT DISORDER 15 0.0005
727 ANOREXIA 6 0.0005
728 MULTI-ORGAN FAILURE 8 0.0005
729 PAIN IN EXTREMITY 136 0.0005
730 DEPRESSION 105 0.0005
731 SWELLING 43 0.0005
732 MUCOSAL INFLAMMATION 12 0.0005
733 CELLULITIS 23 0.0005
734 PHARYNGEAL OEDEMA 7 0.0005
735 RED BLOOD CELL COUNT DECREASED 13 0.0005
736 ROAD TRAFFIC ACCIDENT 19 0.0005
737 HYPERSOMNIA 13 0.0005
738 HAEMATOCHEZIA 25 0.0005
739 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
740 CHILLS 53 0.0005
741 UPPER LIMB FRACTURE 9 0.0005
742 ASTHMA 51 0.0005
743 EAR INFECTION 12 0.0005
744 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 32 0.0004
745 EYE HAEMORRHAGE 6 0.0004
746 PNEUMONIA 145 0.0004
747 THIRST 8 0.0004
748 RENAL FAILURE ACUTE 19 0.0004
749 JOINT RANGE OF MOTION DECREASED 6 0.0004
750 PRODUCT PHYSICAL ISSUE 9 0.0004
751 SNEEZING 10 0.0004
752 INFLAMMATION 23 0.0004
753 EXTRA DOSE ADMINISTERED 18 0.0004
754 CYSTITIS 14 0.0004
755 RESTLESSNESS 16 0.0004
756 AGITATION 32 0.0004
757 GASTROINTESTINAL DISORDER 39 0.0004
758 RESPIRATORY ARREST 12 0.0004
759 NASOPHARYNGITIS 80 0.0004
760 HYPOPHAGIA 11 0.0004
761 DISTURBANCE IN ATTENTION 23 0.0004
762 DEVICE OCCLUSION 6 0.0004
763 BLINDNESS UNILATERAL 6 0.0004
764 CEREBROVASCULAR ACCIDENT 72 0.0004
765 RASH GENERALISED 11 0.0004
766 EATING DISORDER 9 0.0004
767 SYSTEMIC LUPUS ERYTHEMATOSUS 15 0.0004
768 FEELING ABNORMAL 101 0.0004
769 FUNGAL INFECTION 14 0.0004
770 MUSCULOSKELETAL PAIN 22 0.0004
771 SYNCOPE 42 0.0004
772 POOR QUALITY SLEEP 9 0.0004
773 DIABETIC KETOACIDOSIS 10 0.0004
774 PANCREATITIS 22 0.0004
775 HYPOAESTHESIA 62 0.0004
776 LUNG NEOPLASM MALIGNANT 17 0.0004
777 SKIN DISCOLOURATION 19 0.0004
778 PRESCRIBED OVERDOSE 8 0.0004
779 DEHYDRATION 55 0.0004
780 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
781 C-REACTIVE PROTEIN INCREASED 15 0.0004
782 HOT FLUSH 31 0.0004
783 PRESYNCOPE 10 0.0004
784 HEAD INJURY 13 0.0004
785 MULTIPLE SCLEROSIS RELAPSE 28 0.0004
786 PRODUCT DOSE OMISSION ISSUE 120 0.0004
787 KIDNEY INFECTION 8 0.0004
788 LABORATORY TEST ABNORMAL 12 0.0004
789 OEDEMA 22 0.0004
790 DYSGEUSIA 30 0.0004
791 ORTHOSTATIC HYPOTENSION 7 0.0004
792 ORAL PAIN 9 0.0004
793 DEVICE DELIVERY SYSTEM ISSUE 11 0.0004
794 HAEMORRHAGE INTRACRANIAL 6 0.0004
795 THERAPEUTIC RESPONSE UNEXPECTED 18 0.0004
796 DEVICE USE ISSUE 7 0.0004
797 INTENTIONAL PRODUCT MISUSE 35 0.0004
798 SPINAL FRACTURE 8 0.0004
799 CYTOKINE RELEASE SYNDROME 8 0.0004
800 HYPERSENSITIVITY 74 0.0004
801 FULL BLOOD COUNT DECREASED 8 0.0004
802 SLEEP DISORDER 28 0.0004
803 CARDIAC DISORDER 37 0.0004
804 PRODUCT AVAILABILITY ISSUE 9 0.0004
805 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 71 0.0004
806 WOUND 11 0.0004
807 BONE PAIN 23 0.0004
808 OXYGEN SATURATION DECREASED 22 0.0004
809 INJECTION SITE RASH 12 0.0004
810 CEREBRAL HAEMORRHAGE 14 0.0004
811 MUSCLE TWITCHING 9 0.0004
812 MALAISE 171 0.0004
813 INTENTIONAL OVERDOSE 25 0.0004
814 NEUROPATHY PERIPHERAL 37 0.0004
815 LYMPHOMA 6 0.0004
816 LEUKOCYTOSIS 7 0.0004
817 RHINORRHOEA 25 0.0004
818 BLOOD CHOLESTEROL INCREASED 18 0.0004
819 MEMORY IMPAIRMENT 53 0.0004
820 RESPIRATORY TRACT INFECTION 10 0.0004
821 CONFUSIONAL STATE 62 0.0004
822 DRUG INTOLERANCE 37 0.0004
823 ANAPHYLACTIC REACTION 21 0.0004
824 DEPRESSED LEVEL OF CONSCIOUSNESS 15 0.0004
825 ABNORMAL BEHAVIOUR 15 0.0004
826 NEEDLE ISSUE 11 0.0004
827 SOMNOLENCE 76 0.0004
828 OBESITY 6 0.0004
829 RETCHING 8 0.0004
830 MIDDLE INSOMNIA 7 0.0004
831 LOSS OF CONSCIOUSNESS 48 0.0004
832 IMPAIRED WORK ABILITY 8 0.0004
833 ACUTE MYOCARDIAL INFARCTION 11 0.0004
834 DYSARTHRIA 14 0.0004
835 FEAR 10 0.0004
836 INTESTINAL OBSTRUCTION 14 0.0004
837 PAIN OF SKIN 10 0.0004
838 PSORIATIC ARTHROPATHY 15 0.0004
839 COLITIS 14 0.0004
840 RESPIRATORY DISORDER 11 0.0004
841 LUNG DISORDER 18 0.0004
842 MOOD ALTERED 10 0.0004
843 SKIN LESION 10 0.0004
844 LOWER LIMB FRACTURE 7 0.0004
845 COGNITIVE DISORDER 17 0.0004
846 VOMITING 171 0.0004
847 TREATMENT FAILURE 30 0.0004
848 ERUCTATION 7 0.0004
849 LIP SWELLING 12 0.0004
850 URINARY RETENTION 12 0.0004
851 FEELING COLD 10 0.0004
852 ORAL HERPES 7 0.0004
853 CRYING 13 0.0004
854 PERICARDITIS 6 0.0004
855 PANIC ATTACK 13 0.0004
856 TOXICITY TO VARIOUS AGENTS 60 0.0004
857 HAEMATEMESIS 9 0.0004
858 BLOOD PRESSURE ABNORMAL 7 0.0004
859 INTERSTITIAL LUNG DISEASE 17 0.0004
860 HAEMATURIA 12 0.0004
861 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
862 THERAPEUTIC RESPONSE DECREASED 21 0.0003
863 SEIZURE 40 0.0003
864 SEDATION 9 0.0003
865 SPEECH DISORDER 18 0.0003
866 JOINT STIFFNESS 9 0.0003
867 COLD SWEAT 6 0.0003
868 PERITONITIS 7 0.0003
869 GENERAL PHYSICAL HEALTH DETERIORATION 39 0.0003
870 PRODUCT DOSE OMISSION 22 0.0003
871 PULMONARY EMBOLISM 32 0.0003
872 SUICIDE ATTEMPT 20 0.0003
873 STOMATITIS 20 0.0003
874 NEPHROLITHIASIS 15 0.0003
875 ABNORMAL DREAMS 9 0.0003
876 SKIN CANCER 7 0.0003
877 SURGERY 19 0.0003
878 PRODUCT QUALITY ISSUE 44 0.0003
879 DEVICE LEAKAGE 14 0.0003
880 VAGINAL HAEMORRHAGE 14 0.0003
881 DEVICE DISLOCATION 14 0.0003
882 SKIN EXFOLIATION 27 0.0003
883 BLINDNESS 13 0.0003
884 UNEVALUABLE EVENT 24 0.0003
885 IRRITABILITY 19 0.0003
886 INTENTIONAL DOSE OMISSION 9 0.0003
887 PROTEINURIA 6 0.0003
888 MUSCULOSKELETAL DISORDER 6 0.0003
889 COLITIS ULCERATIVE 14 0.0003
890 BLOOD GLUCOSE DECREASED 15 0.0003
891 RASH PAPULAR 7 0.0003
892 DRUG PRESCRIBING ERROR 6 0.0003
893 EXPOSURE VIA SKIN CONTACT 8 0.0003
894 AMNESIA 20 0.0003
895 JOINT SWELLING 37 0.0003
896 MENORRHAGIA 6 0.0003
897 DISORIENTATION 12 0.0003
898 RECTAL HAEMORRHAGE 13 0.0003
899 ERYTHEMA 62 0.0003
900 DEVICE ISSUE 27 0.0003
901 VISUAL ACUITY REDUCED 10 0.0003
902 ACCIDENTAL OVERDOSE 11 0.0003
903 INJECTION SITE ERYTHEMA 37 0.0003
904 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
905 DISEASE PROGRESSION 35 0.0003
906 ANGER 10 0.0003
907 RASH PRURITIC 16 0.0003
908 EMOTIONAL DISORDER 9 0.0003
909 GASTRIC DISORDER 10 0.0003
910 ADVERSE DRUG REACTION 26 0.0003
911 PROCEDURAL PAIN 8 0.0003
912 CEREBRAL INFARCTION 7 0.0003
913 INJECTION SITE URTICARIA 7 0.0003
914 DEPRESSED MOOD 15 0.0003
915 LACTIC ACIDOSIS 9 0.0003
916 HAEMORRHAGE 29 0.0003
917 DEEP VEIN THROMBOSIS 18 0.0003
918 ERECTILE DYSFUNCTION 7 0.0003
919 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 7 0.0003
920 DEVICE BREAKAGE 11 0.0003
921 PSYCHOTIC DISORDER 8 0.0003
922 EXPIRED PRODUCT ADMINISTERED 9 0.0003
923 INJECTION SITE PRURITUS 18 0.0003
924 CORONARY ARTERY DISEASE 8 0.0003
925 RASH MACULAR 9 0.0003
926 RHEUMATOID ARTHRITIS 29 0.0003
927 NEOPLASM MALIGNANT 17 0.0003
928 INCORRECT DOSE ADMINISTERED 57 0.0002
929 DRUG DOSE OMISSION 41 0.0002
930 FIBROMYALGIA 6 0.0002
931 IMPAIRED HEALING 8 0.0002
932 THERAPEUTIC RESPONSE SHORTENED 8 0.0002
933 HOSPITALISATION 37 0.0002
934 SUICIDAL IDEATION 22 0.0002
935 COMPLETED SUICIDE 20 0.0002
936 PSORIASIS 31 0.0002
937 THROMBOSIS 19 0.0002
938 RENAL DISORDER 11 0.0002
939 ARTHROPATHY 13 0.0002
940 MEDICATION ERROR 13 0.0002
941 HAEMATOMA 6 0.0002
942 NIGHTMARE 8 0.0002
943 PLASMA CELL MYELOMA 9 0.0002
944 MENTAL DISORDER 10 0.0002
945 ECZEMA 12 0.0002
946 DRUG ADMINISTRATION ERROR 7 0.0002
947 INFUSION RELATED REACTION 15 0.0002
948 FEMUR FRACTURE 7 0.0002
949 MENSTRUATION IRREGULAR 6 0.0002
950 SKIN BURNING SENSATION 16 0.0002
951 THERAPEUTIC PRODUCT EFFECT DECREASED 10 0.0002
952 MOOD SWINGS 7 0.0002
953 DEATH 187 0.0002
954 MALIGNANT NEOPLASM PROGRESSION 22 0.0002
955 INCORRECT DRUG ADMINISTRATION DURATION 6 0.0002
956 INJECTION SITE BRUISING 17 0.0002
957 VIRAL INFECTION 7 0.0002
958 COMA 10 0.0002
959 ADVERSE EVENT 19 0.0002
960 ACCIDENTAL EXPOSURE TO PRODUCT 21 0.0002
961 ILL-DEFINED DISORDER 12 0.0002
962 INJECTION SITE PAIN 59 0.0002
963 NERVOUS SYSTEM DISORDER 6 0.0002
964 INJECTION SITE MASS 7 0.0002
965 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 13 0.0002
966 OSTEONECROSIS 6 0.0002
967 DRUG DOSE OMISSION BY DEVICE 14 0.0002
968 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 36 0.0002
969 NO ADVERSE EVENT 32 0.0002
970 NEOPLASM PROGRESSION 6 0.0002
971 DEVICE MALFUNCTION 12 0.0002
972 INCORRECT ROUTE OF DRUG ADMINISTRATION 6 0.0002
973 MULTIPLE SCLEROSIS 8 0.0002
974 OVERDOSE 36 0.0002
975 UNDERDOSE 12 0.0002
976 MYOCARDIAL INFARCTION 28 0.0002
977 PRODUCT STORAGE ERROR 14 0.0002
978 SKIN IRRITATION 7 0.0002
979 DERMATITIS ATOPIC 8 0.0002
980 ABORTION SPONTANEOUS 6 0.0001
981 DRUG WITHDRAWAL SYNDROME 13 0.0001
982 INJECTION SITE SWELLING 11 0.0001
983 CONVULSION 8 0.0001
984 INJECTION SITE HAEMORRHAGE 11 0.0001
985 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
986 BREAST CANCER 12 0.0001
987 RENAL CANCER 6 0.0001
988 AGGRESSION 6 0.0001
989 ACNE 8 0.0001
990 INJECTION SITE REACTION 7 0.0001
991 PROSTATE CANCER 6 0.0001